This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moraes, M. P.
Right arrow Articles by Grubman, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moraes, M. P.
Right arrow Articles by Grubman, M. J.

 Previous Article  |  Next Article 

Journal of Virology, July 2007, p. 7124-7135, Vol. 81, No. 13
0022-538X/07/$08.00+0     doi:10.1128/JVI.02775-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons{triangledown}

Mauro Pires Moraes,1 Teresa de los Santos,1 Marla Koster,1 Traci Turecek,1 He Wang,2 Vladimir G. Andreyev,1,{dagger} and Marvin J. Grubman1*

Plum Island Animal Disease Center, North Atlantic Area, Agricultural Research Service, U.S. Department of Agriculture, Greenport, New York 11944,1 Foreign Animal Disease Diagnostic Laboratory, Plum Island Animal Disease Center, Animal Plant and Health Inspection Service, U.S. Department of Agriculture, Greenport, New York 119442

Received 15 December 2006/ Accepted 13 April 2007

Previously, we showed that type I interferon (alpha/beta interferon [IFN-{alpha}/ß]) can inhibit foot-and-mouth disease virus (FMDV) replication in cell culture, and swine inoculated with 109 PFU of human adenovirus type 5 expressing porcine IFN-{alpha} (Ad5-pIFN-{alpha}) were protected when challenged 1 day later. In this study, we found that type II pIFN (pIFN-{gamma}) also has antiviral activity against FMDV in cell culture and that, in combination with pIFN-{alpha}, it has a synergistic antiviral effect. We also observed that while each IFN alone induced a number of IFN-stimulated genes (ISGs), the combination resulted in a synergistic induction of some ISGs. To extend these studies to susceptible animals, we inoculated groups of swine with a control Ad5, 108 PFU of Ad5-pIFN-{alpha}, low- or high-dose Ad5-pIFN-{gamma}, or a combination of Ad5-pIFN-{alpha} and low- or high-dose Ad5-pIFN-{gamma} and challenged all groups with FMDV 1 day later. The control group and the groups inoculated with either Ad5-pIFN-{alpha} or a low dose of Ad5-pIFN-{gamma} developed clinical disease and viremia. However, the group that received the combination of both Ad5-IFNs with the low dose of Ad5-pIFN-{gamma} was completely protected from challenge and had no viremia. Similarly the groups inoculated with the combination of Ad5s with the higher dose of Ad5-pIFN-{gamma} or with only high-dose Ad5-pIFN-{gamma} were protected. The protected animals did not develop antibodies against viral nonstructural (NS) proteins, while all infected animals were NS protein seropositive. No antiviral activity or significant levels of IFNs were detected in the protected groups, but there was an induction of some ISGs. The results indicate that the combination of type I and II IFNs act synergistically to inhibit FMDV replication in vitro and in vivo.

* Corresponding author. Mailing address: Plum Island Animal Disease Center, USDA, ARS, NAA, P.O. Box 848, Greenport, NY 11944. Phone: (631) 323-3329. Fax: (631) 323-3006. E-mail: marvin.grubman{at}ars.usda.gov

{triangledown} Published ahead of print on 25 April 2007.

{dagger} Present address: Laboratory of Gene Engineering, All-Russian Research Institute for Animal Health, Vladimir, Russia.

Journal of Virology, July 2007, p. 7124-7135, Vol. 81, No. 13
0022-538X/07/$08.00+0     doi:10.1128/JVI.02775-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Diaz-San Segundo, F., Moraes, M. P., de los Santos, T., Dias, C. C. A., Grubman, M. J. (2010). Interferon-Induced Protection against Foot-and-Mouth Disease Virus Infection Correlates with Enhanced Tissue-Specific Innate Immune Cell Infiltration and Interferon-Stimulated Gene Expression. J. Virol. 84: 2063-2077 [Abstract] [Full Text]  
  • Shen, Y. B., Piao, X. S., Kim, S. W., Wang, L., Liu, P., Yoon, I., Zhen, Y. G. (2009). Effects of yeast culture supplementation on growth performance, intestinal health, and immune response of nursery pigs. J ANIM SCI 87: 2614-2624 [Abstract] [Full Text]  
  • Toka, F. N., Nfon, C. K., Dawson, H., Golde, W. T. (2009). Accessory-Cell-Mediated Activation of Porcine NK Cells by Toll-Like Receptor 7 (TLR7) and TLR8 Agonists. CVI 16: 866-878 [Abstract] [Full Text]  
  • de los Santos, T., Diaz-San Segundo, F., Zhu, J., Koster, M., Dias, C. C. A., Grubman, M. J. (2009). A Conserved Domain in the Leader Proteinase of Foot-and-Mouth Disease Virus Is Required for Proper Subcellular Localization and Function. J. Virol. 83: 1800-1810 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»